Author: Oberlander, T.F.; Zwaigenbaum, L.
Description: Over the past decade, scientific and public attention has focused on reports of an increased risk for autism spectrum disorder in children of depressed mothers treated with an antidepressant medication during pregnancy.1 However, evidence supporting an association between in utero exposure to antidepressant medications, especially selective serotonin reuptake inhibitors, and adverse long-term neurodevelopmental outcomes remains inconclusive.2 Methodological constraints limit the ability to account for the effect of variations in severity of maternal depression, and randomizing exposure to an antidepressant medication during pregnancy would not be ethical.
Subject Headings: Antidepressive Agents/therapeutic use; Autistic Disorder/drug therapy; Child; Depression; Depressive Disorder/drug therapy; Female; Humans; Pregnancy; Pregnancy Complications/drug therapy; Prenatal Exposure Delayed Effects/drug therapy
Keywords: Disentangling Maternal Depression and Antidepressant Use During Pregnancy as Risks for Autism in Children
Publication year: 2017
Journal or book title: JAMA
Volume: 317
Issue: 15
Pages: 1533-1534
Find the full text : https://jamanetwork.com/journals/jama/article-abstract/2618602
Find more like this one (cited by): https://scholar.google.com/scholar?cites=3125285142405508086&as_sdt=1000005&sciodt=0,16&hl=en
Type: Journal Article
Serial number: 2950